// App-Quantinova.ai

TCT-45 : Long Term Safety and Effectiveness of XIENCE V Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V USA Study

Researchers

Presenter

  • James Hermiller Jr

Principal Investigators

  • Mitchell Krucoff

  • weiying zhao

  • Luis Gruberg

  • William Lombardi

  • David Rutledge

  • Jin Wang

  • Vivian Mao

Medical Centers

  • N/A, Indianapolis, Indiana

  • Duke Clinical Research Institute, Durham, NC

Locations

  • United States

Companies

  • Abbott

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Chronic total occlusion

  • Renal insufficiency

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved